Are you involved in cell engineering research and eager to bridge the gap from the lab to real-world clinical applications? We invite you to an informative seminar on Scalable Cell Engineering from 12:00 to 1:30 (PT) pm for a Cell Engineering Seminar hosted by the Steve Feldman Lab at Stanford.
Hear from our special guest speaker, Vimal Keerthi, who will present his work utilizing the MaxCyte platform on homology-independent targeted insert for CAR-T cell generation at clinical scale. Our MaxCyte presenters will also demonstrate how customers use the MaxCyte scalable transfection platform to edit primary cells, stem cells, and other hard-to-transfect cell lines while maintaining high efficiency and viability regardless of application.
Register to learn more about how academic & and industry labs utilize MaxCyte and FCDI’s enabling technologies to efficiently engineer primary cells, stem cells, and cell lines all while maintaining high cell viabilities & recovery.